FASTER, BETTER, AFFORDABLE.
BiotechNEWS has recently interviewed our CEO, Kees van den Berg. According to Kees, the future of diagnostics is all about personalized medicine. In this article (in Dutch), he describes the expansion of GenomeScan and the relationship with LUMC and ErasmusMC. He also highlights the current trends in NGS and comments on future developments in healthcare. Enjoy…
Published in BiotechNEWS – Number 2 – December 2019